Anti Inflammatory

Showing all 5 results

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.

Social Networks

Useful Links

Specialized Offerings

HPAPI

API

ADC Linkers

Polyethylene Glycol (PEGs)

Corporate Office Address:

Manufacturing Site Address:

Offering CDMO Services from Discovery to Commercialization

With a strong international footprint, Shilpa Pharma serves partners across key markets worldwide:

India
United States
Canada
China
Germany
France
Japan
Central America States
Brazil
Australia
Singapore
Taiwan
UAE
Saudi Arabia
South Korea
Russia
Egypt
South Africa
United Kingdom & Continental Europe
ROW Markets

Fill the Form

Name

Your Contact Number

Job Title

Your Company

Select

Country

Message

Anti Inflammatory

((1S,4R)-4-aminocyclopent-2-en-1-yl)methanol (2S,3S)-2,3-dihydroxysuccinate

3-Hydroxy Acetophenone

4-isothiocyanato-2-(trifluoromethyl)benzonitrile (Enzalutamide KSM-III)

Ibrutinib

S-2-Aminobutanamide hydrochloride (Levetiracetam KSM-I)